Skip to main content

Closed

ASND: Ascendis Pharma A/S Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth+36.3% / yr

Operating margin-0.8%

ROIC1.5%

Financially safe

Stretched

Debt / equity1.84×

Interest coverage-0.0×

Current ratio1.00×

Valuation

Unrated

P/E ratio25.8×

Ascendis Pharma A/S

ASNDNASDAQ Global Select·USD·Closed

Ascendis Pharma A/S

ASNDNASDAQ·USD·Closed

$243.91

−2.85%

$243.91

−$7.16 (2.85%)

52W Range

65thpctl

Volume

0.73×avg

Mkt Cap

15.15BUSD

P/E

25.8TTM

Div Yield

–ann

52W Range

65thpctl

Volume

0.73×avg

Market Cap

15.15BUSD

P/E Ratio

25.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings